A significant decline and delay in time from symptom onset to first medical contact of cardiac admissions translated into higher inpatient mortality, with a poorer cardiac outcome upon follow-up, with higher N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and a lower ejection fraction in patients admitted during early COVID-19 period [17]. The gene discussed is NPPB; the disease is COVID-19.